secwatch / observer
8-K filed March 19, 2025, 7:59 PM ET ticker IBRX CIK 0001326110
other material confidence high sentiment neutral materiality 0.35

ImmunityBio, Inc. (IBRX): auditor change — ImmunityBio replaces auditor EY with Deloitte for fiscal year 2025

ImmunityBio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.99

ImmunityBio, Inc. engaged Deloitte & Touche LLP as its auditor.

Action
engagement
Auditor
Deloitte & Touche LLP
Exact text from the filing
On March 13, 2025, the Audit Committee approved the engagement of Deloitte & Touche LLP ("Deloitte") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, subject to Deloitte's customary client acceptance procedures.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.99

ImmunityBio, Inc. dismissed Ernst & Young LLP as its auditor.

Action
dismissal
Auditor
Ernst & Young LLP
Exact text from the filing
On March 13, 2025, the Audit Committee of the Board of Directors (the "Audit Committee") of ImmunityBio, Inc. (the "Company"), approved the dismissal of Ernst & Young LLP ("EY") as the Company's independent registered public accounting firm.
View on SEC.gov

Browse all auditor changes →

ImmunityBio, Inc. filing history →

Source: SEC EDGAR
accession 0001326110-25-000040
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.